# Cresilon, Inc.

- Location (FDA's records): Brooklyn, NY
- FDA decisions: 3 (2023–2025): 3 510(k) clearances
- Product codes: QSY (3)
- Predicates its devices cite: 5 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Medtrade Products, Ltd.: 2 (https://510kreport.com/company/medtrade-products)
- Gel-E, Inc.: 1 (https://510kreport.com/company/gel-e)

## Firms that cite its devices most
- Machina Medical, Inc.: 1 (https://510kreport.com/company/machina-medical)

## Its most-cited devices
- K240713: Traumagel® (2024), cited by 2
- K213652: Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG) (2023), cited by 1

## Recent decisions
- K253609: TRAUMAGEL® 2.0 Hemostatic Gel (Dec 12, 2025)
- K240713: Traumagel® (Aug 14, 2024)
- K213652: Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG) (Jun 28, 2023)

Source page: https://510kreport.com/company/cresilon